Bristol Myers adds liver monitoring to Phase 3 trial of fibrosis drug admilparant
A spokesperson confirmed a limited number of liver-related events, including one patient death whose cause is unclear.
Intelligence
The parties
Activity
A spokesperson confirmed a limited number of liver-related events, including one patient death whose cause is unclear.
Intelligence
Activity